BEYAZ (drospirenone; ethinyl estradiol; levomefolate calcium) Drug Profile, 2025: BEYAZ (drospirenone; ethinyl estradiol; levomefolate calcium) drug patents, patent challenges, litigation, SPCs, drug prices, drug prices, annual drug sames, suppliers, API

Drugpatentwatch

SANCUSO Drug Profile: SANCUSO (granisetron) drug patents, FDA exclusivity, litigation, drug prices

€ 103,25

Drugpatentwatch

OSPHENA Drug Profile: OSPHENA (ospemifene) drug patents, FDA exclusivity, litigation, drug prices

€ 103,25

Drugpatentwatch

FORTEO Drug Profile: FORTEO (teriparatide) drug patents, FDA exclusivity, litigation, drug prices

€ 103,25

Drugpatentwatch

STENDRA Drug Profile: STENDRA (avanafil) drug patents, FDA exclusivity, litigation, drug prices

€ 103,25

Drugpatentwatch

ELLA Drug Profile: ELLA (ulipristal acetate) drug patents, FDA exclusivity, litigation, drug prices

€ 103,25

Drugpatentwatch

NATROBA Drug Profile: NATROBA (spinosad) drug patents, FDA exclusivity, litigation, drug prices

€ 103,25

Drugpatentwatch

TRULANCE Drug Profile: TRULANCE (plecanatide) drug patents, FDA exclusivity, litigation, drug prices

€ 103,25

Drugpatentwatch

XIIDRA Drug Profile: XIIDRA (lifitegrast) drug patents, FDA exclusivity, litigation, drug prices

€ 103,25

Drugpatentwatch

OMNARIS Drug Profile: OMNARIS (ciclesonide) drug patents, FDA exclusivity, litigation, drug prices

€ 103,25

Drugpatentwatch

VIBERZI Drug Profile: VIBERZI (eluxadoline) drug patents, FDA exclusivity, litigation, drug prices

€ 103,25